Putin discusses Russia’s economy growth with ministersBusiness & Economy September 24, 2:38
Lavrov warns against partition of SyriaRussian Politics & Diplomacy September 23, 0:00
Lavrov calls to coordinate Russian, US military action in SyriaRussian Politics & Diplomacy September 22, 21:05
Lavrov blames Obama administration for souring Russia-US tiesRussian Politics & Diplomacy September 22, 20:41
Waging war on Korean Peninsula inadmissible, says LavrovRussian Politics & Diplomacy September 22, 20:36
Russian Northern Fleet completes drills in ArcticMilitary & Defense September 22, 18:01
OPEC and non-OPEC countries to continue talks on oil production cut dealBusiness & Economy September 22, 17:28
Russian pair figure skaters Kavaguti, Smirnov retire from sportSport September 22, 16:48
Record number of delegations register for St. Petersburg-hosted IPU AssemblyRussian Politics & Diplomacy September 22, 16:47
MOSCOW, April 22. /TASS/. A temporary suspension term of Russian national water polo team’s player Alexey Bugaichuk, imposed last month after he tested positive for banned performance enhancing drug meldonium, has been cancelled, the Russian Water Polo Federation told TASS on Friday.
"Bugaichuk’s temporary suspension has been lifted," a spokesman for the RWPF said in an interview with TASS.
Bugaichuk was subjected to a doping test on January 18 at the 2016 Men's European Water Polo Championship, held in Serbia’s Belgrade on January 10-23. In March, the Russian Water Polo Federation announced that January’s doping test of Bugaichuk revealed remaining traces of meldonium in his body system.
The World Anti-Doping Agency (WADA) announced on April 13 that the concentration of less than one microgram of meldonium in the body system of an athlete, whose doping tests were conducted before March 1, was acceptable.
The drug meldonium (mildronate) was included in the list of preparations banned by WADA from January 1, 2016. The presence of the meldonium substance in the athlete’s blood during and between competitions is a violation of anti-doping rules. The substance belongs to S4 class on the WADA blacklist (hormones and metabolic modulators).
Meldronate is a cardiovascular preparation freely available for purchase at pharmacies across Russia without doctor’s prescription.